Abstract
This report provides a comprehensive analysis of the global Endothelial Keratoplasty (EK) market, which is projected to experience significant growth through 2032. The study examines key cornea transplant techniques, specifically DSEK and DMEK, and segments the market by application and geography, including major regions like the Americas, APAC, and Europe. By evaluating competitive landscapes, emerging trends, and key industry players, the report offers strategic insights into the drivers shaping the future trajectory of this specialized ophthalmic sector.
Related Questions
US$ 156 million in 2025
19.4% from 2026 to 2032
Mayo Clinic, Cellusion, LaserVision, Precise Bio, Altomed, CorneaGen
Summary
Market Overview
Global Market Forecast
The global Endothelial Keratoplasty (EK) market size is predicted to grow from US$ 156 million in 2025 to US$ 529 million in 2032, representing a compound annual growth rate (CAGR) of 19.4% from 2026 to 2032.
Regional Market Outlook
- United States: The market for Endothelial Keratoplasty (EK) in the United States is estimated to experience steady growth from 2025 through 2032.
- China: The market for Endothelial Keratoplasty (EK) in China is estimated to undergo expansion between 2025 and 2032.
- Europe: The market for Endothelial Keratoplasty (EK) in Europe is estimated to increase over the forecast period from 2025 to 2032.
Product Definition and Clinical Application
Endothelial keratoplasty (EK) is a cornea transplant technique that serves as the preferred method to restore vision when the inner cell layer of the cornea ceases to function properly. This dysfunction may be caused by:
- Fuchs’ dystrophy
- Bullous keratopathy
- Iridocorneal endothelial (ICE) syndrome
- Other endothelial disorders
EK is characterized by its ability to selectively replace only the diseased layer of the cornea while leaving healthy areas intact.
Report Scope and Methodology
Research Objectives
LPI (LP Information)'s newest research report, titled “Endothelial Keratoplasty (EK) Industry Forecast,” provides a comprehensive analysis of the global Endothelial Keratoplasty (EK) landscape. The report achieves the following:
- Sales Analysis: Reviews total world Endothelial Keratoplasty (EK) sales in 2025 and examines past sales data.
- Projected Sales: Provides a detailed analysis in US$ millions of projected Endothelial Keratoplasty (EK) sales for the period of 2026 through 2032, broken down by region, market sector, and sub-sector.
- Market Dynamics: Highlights key trends related to product segmentation, company formation, revenue, market share, latest developments, and M&A activity.
- Competitive Intelligence: Analyzes the strategies of leading global companies, focusing on their EK portfolios and capabilities, market entry strategies, market positions, and geographic footprints to understand their unique positions in an accelerating market.
- Strategic Insights: Evaluates key market trends, drivers, and affecting factors shaping the global outlook to highlight emerging pockets of opportunity.
Methodology
The study utilizes a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, offering a highly nuanced view of the current state and future trajectory of the global Endothelial Keratoplasty (EK) industry.
Market Segmentation
By Type
- Descemet's Stripping Endothelial Keratoplasty (DSEK)
- Descemet's Membrane Endothelial Keratosplaty (DMEK)
By Application
- Adults
- Children
By Region
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
Competitive Landscape
Key Market Trends
The report examines market shares and growth opportunities across product types, applications, key players, and key regions/countries. In terms of revenue, the global two largest companies are expected to hold a significant portion of the market share in 2025.
Key Players
The following companies have been profiled based on inputs gathered from primary experts and an analysis of their coverage, product portfolio, and market penetration:
- Mayo Clinic
- Cellusion
- LaserVision
- Precise Bio
- Altomed
- CorneaGen
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Endothelial Keratoplasty (EK) Market Size (2021-2032)
2.1.2 Endothelial Keratoplasty (EK) Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Endothelial Keratoplasty (EK) by Country/Region (2021, 2025 & 2032)
2.2 Endothelial Keratoplasty (EK) Segment by Type
2.2.1 Descemet's Stripping Endothelial Keratoplasty (DSEK)
2.2.2 Descemet's Membrane Endothelial Keratosplaty (DMEK)
2.2.3 Endothelial Keratoplasty (EK) Market Size by Type
- 2.2.3.1 Endothelial Keratoplasty (EK) Market Size CAGR by Type (2021 VS 2025 VS 2032)
- 2.2.3.2 Global Endothelial Keratoplasty (EK) Market Size Market Share by Type (2021-2026)
2.3 Endothelial Keratoplasty (EK) Segment by Application
2.3.1 Adults
2.3.2 Children
2.3.3 Endothelial Keratoplasty (EK) Market Size by Application
- 2.3.3.1 Endothelial Keratoplasty (EK) Market Size CAGR by Application (2021 VS 2025 VS 2032)
- 2.3.3.2 Global Endothelial Keratoplasty (EK) Market Size Market Share by Application (2021-2026)
3 Endothelial Keratoplasty (EK) Market Size by Player
3.1 Endothelial Keratoplasty (EK) Market Size Market Share by Player
3.1.1 Global Endothelial Keratoplasty (EK) Revenue by Player (2021-2026)
3.1.2 Global Endothelial Keratoplasty (EK) Revenue Market Share by Player (2021-2026)
3.2 Global Endothelial Keratoplasty (EK) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Endothelial Keratoplasty (EK) by Region
4.1 Endothelial Keratoplasty (EK) Market Size by Region (2021-2026)
4.2 Global Endothelial Keratoplasty (EK) Annual Revenue by Country/Region (2021-2026)
4.3 Americas Endothelial Keratoplasty (EK) Market Size Growth (2021-2026)
4.4 APAC Endothelial Keratoplasty (EK) Market Size Growth (2021-2026)
4.5 Europe Endothelial Keratoplasty (EK) Market Size Growth (2021-2026)
4.6 Middle East & Africa Endothelial Keratoplasty (EK) Market Size Growth (2021-2026)
5 Americas
5.1 Americas Endothelial Keratoplasty (EK) Market Size by Country (2021-2026)
5.2 Americas Endothelial Keratoplasty (EK) Market Size by Type (2021-2026)
5.3 Americas Endothelial Keratoplasty (EK) Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Endothelial Keratoplasty (EK) Market Size by Region (2021-2026)
6.2 APAC Endothelial Keratoplasty (EK) Market Size by Type (2021-2026)
6.3 APAC Endothelial Keratoplasty (EK) Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Endothelial Keratoplasty (EK) Market Size by Country (2021-2026)
7.2 Europe Endothelial Keratoplasty (EK) Market Size by Type (2021-2026)
7.3 Europe Endothelial Keratoplasty (EK) Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Endothelial Keratoplasty (EK) by Region (2021-2026)
8.2 Middle East & Africa Endothelial Keratoplasty (EK) Market Size by Type (2021-2026)
8.3 Middle East & Africa Endothelial Keratoplasty (EK) Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Endothelial Keratoplasty (EK) Market Forecast
10.1 Global Endothelial Keratoplasty (EK) Forecast by Region (2027-2032)
10.1.1 Global Endothelial Keratoplasty (EK) Forecast by Region (2027-2032)
10.1.2 Americas Endothelial Keratoplasty (EK) Forecast
10.1.3 APAC Endothelial Keratoplasty (EK) Forecast
10.1.4 Europe Endothelial Keratoplasty (EK) Forecast
10.1.5 Middle East & Africa Endothelial Keratoplasty (EK) Forecast
10.2 Americas Endothelial Keratoplasty (EK) Forecast by Country (2027-2032)
10.2.1 United States Market Endothelial Keratoplasty (EK) Forecast
10.2.2 Canada Market Endothelial Keratoplasty (EK) Forecast
10.2.3 Mexico Market Endothelial Keratoplasty (EK) Forecast
10.2.4 Brazil Market Endothelial Keratoplasty (EK) Forecast
10.3 APAC Endothelial Keratoplasty (EK) Forecast by Region (2027-2032)
10.3.1 China Endothelial Keratoplasty (EK) Market Forecast
10.3.2 Japan Market Endothelial Keratoplasty (EK) Forecast
10.3.3 Korea Market Endothelial Keratoplasty (EK) Forecast
10.3.4 Southeast Asia Market Endothelial Keratoplasty (EK) Forecast
10.3.5 India Market Endothelial Keratoplasty (EK) Forecast
10.3.6 Australia Market Endothelial Keratoplasty (EK) Forecast
10.4 Europe Endothelial Keratoplasty (EK) Forecast by Country (2027-2032)
10.4.1 Germany Market Endothelial Keratoplasty (EK) Forecast
10.4.2 France Market Endothelial Keratoplasty (EK) Forecast
10.4.3 UK Market Endothelial Keratoplasty (EK) Forecast
10.4.4 Italy Market Endothelial Keratoplasty (EK) Forecast
10.4.5 Russia Market Endothelial Keratoplasty (EK) Forecast
10.5 Middle East & Africa Endothelial Keratoplasty (EK) Forecast by Region (2027-2032)
10.5.1 Egypt Market Endothelial Keratoplasty (EK) Forecast
10.5.2 South Africa Market Endothelial Keratoplasty (EK) Forecast
10.5.3 Israel Market Endothelial Keratoplasty (EK) Forecast
10.5.4 Turkey Market Endothelial Keratoplasty (EK) Forecast
10.6 Global Endothelial Keratoplasty (EK) Forecast by Type (2027-2032)
10.7 Global Endothelial Keratoplasty (EK) Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Endothelial Keratoplasty (EK) Forecast
11 Key Players Analysis
11.1 Mayo Clinic
11.1.1 Mayo Clinic Company Information
11.1.2 Mayo Clinic Endothelial Keratoplasty (EK) Product Offered
11.1.3 Mayo Clinic Endothelial Keratoplasty (EK) Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Mayo Clinic Main Business Overview
11.1.5 Mayo Clinic Latest Developments
11.2 Cellusion
11.2.1 Cellusion Company Information
11.2.2 Cellusion Endothelial Keratoplasty (EK) Product Offered
11.2.3 Cellusion Endothelial Keratoplasty (EK) Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Cellusion Main Business Overview
11.2.5 Cellusion Latest Developments
11.3 LaserVision
11.3.1 LaserVision Company Information
11.3.2 LaserVision Endothelial Keratoplasty (EK) Product Offered
11.3.3 LaserVision Endothelial Keratoplasty (EK) Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 LaserVision Main Business Overview
11.3.5 LaserVision Latest Developments
11.4 Precise Bio
11.4.1 Precise Bio Company Information
11.4.2 Precise Bio Endothelial Keratoplasty (EK) Product Offered
11.4.3 Precise Bio Endothelial Keratoplasty (EK) Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Precise Bio Main Business Overview
11.4.5 Precise Bio Latest Developments
11.5 Altomed
11.5.1 Altomed Company Information
11.5.2 Altomed Endothelial Keratoplasty (EK) Product Offered
11.5.3 Altomed Endothelial Keratoplasty (EK) Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Altomed Main Business Overview
11.5.5 Altomed Latest Developments
11.6 CorneaGen
11.6.1 CorneaGen Company Information
11.6.2 CorneaGen Endothelial Keratoplasty (EK) Product Offered
11.6.3 CorneaGen Endothelial Keratoplasty (EK) Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 CorneaGen Main Business Overview
11.6.5 CorneaGen Latest Developments
12 Research Findings and Conclusion